Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
S. Spisak, D. Chen, P. Likasitwatanakul, P. Doan, Z. Li, P. Bala, L. Vizkeleti, P. De Silva, M. Giannakis, B. Wolpin, J. Qi, N. Sethi
bioRxiv · Jun 21, 2023 · PreprintCancer Biology
A. Prosz, H. Duan, V. Tisza, P. Sahgal, S. Topka, G. T.Klus, J. Borscok, Z. Sztupinszki, T. Hanlon, M. Diossy, L. Vizkeleti, D. R. Stormoen, I. Csabai, H. Pappot, J. Vijai, , Z. Szallasi
This paper identifies NER deficiency as a targetable vulnerability in ccRCC, showing that 10% of patients may respond to irofulven based on mutational signatures and PTGR1 expression.
bioRxiv · Feb 7, 2023Cancer Biology
L. Vizkeleti, C. Kiss, V. Tisza, A. Szigeti, A. Gellert, I. Csabai, L. S. Pongor, S. Spisak
This study investigates the epigenetic regulation of Septin9 variants in colorectal cancer, finding hypermethylation at the v2 promoter leads to alternative transcription and potential functional differences.
bioRxiv · Jan 31, 2023 · PreprintCancer Biology
J. Gil, Y. Kim, B. Szeitz, V. Doma, U. Cakır, N. Pinto de Almeida, Y. Paco Hagemeijer, V. Guryev, J. G. Johansson, Y. Sharma, I. Pla Parada, Z. Horvath, J. de Siqueira Guedes, G. Monnerat, F. C. Nogueira, , G. Marko-Varga
This paper analyzes proteogenomic data from melanoma patients to show how metastatic melanoma alters metabolism and immune responses to evade immune detection.
bioRxiv · Apr 10, 2021 · PreprintCancer Biology
A.-M. Tokes, O. Rusz, G. Cserni, E. Toth, G. Rubovszky, T. Tokes, L. Vizkeleti, L. Reiniger, R. Koszo, Z. Kahan, J. Kulka, M. Donia, A. Voros, Z. Szallasi
This study examines how mutagenic and non-mutagenic pre-operative chemotherapy affects immune infiltration in breast cancer, finding that increased stromal tumor-infiltrating lymphocytes (StrTIL) correlates with better distant metastasis-free survival in HR-negative cases.
bioRxiv · Oct 29, 2018Cancer Biology